Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
126,273,814
Number of holders
140
Total 13F shares, excl. options
49,939,204
Shares change
+24,943,386
Total reported value, excl. options
$830,012,497
Value change
+$410,032,084
Put/Call ratio
1.1%
Number of buys
113
Number of sells
-38
Price
$16.62

Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q2 2021

165 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q2 2021.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 49,939,204 shares of 126,273,814 outstanding shares and own 39.55% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (7,222,127 shares), BlackRock Inc. (7,021,173 shares), STATE STREET CORP (4,244,681 shares), VANGUARD GROUP INC (2,823,624 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2,108,452 shares), MORGAN STANLEY (1,849,595 shares), NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC (1,657,440 shares), PURA VIDA INVESTMENTS, LLC (1,281,600 shares), GOLDMAN SACHS GROUP INC (1,152,423 shares), and MILLENNIUM MANAGEMENT LLC (990,447 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.